Denmark approves generic copy of GSK's top-selling lung drug

LONDON (Reuters) - Denmark has approved the sale of a generic copy of GlaxoSmithKline's $8 billion-a-year inhaled lung drug Advair, threatening future sales of the British firm's biggest product.

Source: Reuters: Health - December 18, 2013 Category: Consumer Health News Tags: healthNews Source Type: news